[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-383116-105":59,"doc-detail-383116-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","protooncogenic-role-of-arhgap11a-and-arhgap11b-in-invasive-ductal-carcinoma-two-promising-breast-cancer-biomarkers","Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma - Two Promising Breast Cancer Biomarkers","","Invasive ductal carcinoma (IDC) remains a leading cause of breast cancer mortality due to high malignancy, metastasis, recurrence, and death rates. This study evaluates the expression of two RhoGAP genes, ARHGAP11A and ARHGAP11B, in The Cancer Genome Atlas (TCGA) and 51 IDC tumors versus matched normal tissues using qPCR. TCGA shows elevated expression across cancers, with gene correlations in TCGA-BRCA, and methylation inversely associated with overexpression. Expression is upregulated in tumor samples, with ARHGAP11A linked to breastfeeding status and menstrual/menarche timing, and ARHGAP11B elevated in HER2-positive tumors. Results support protooncogenic roles and propose these genes as novel diagnostic and prognostic biomarkers for IDC.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/protooncogenic-role-of-arhgap11a-and-arhgap11b-in-invasive-ductal-carcinoma-two-promising-breast-cancer-biomarkers/383116/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/protooncogenic-role-of-arhgap11a-and-arhgap11b-in-invasive-ductal-carcinoma-two-promising-breast-cancer-biomarkers/383116.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-24",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main focus of the study?","Question",{"text":113,"@type":114},"The study investigates the protooncogenic role of ARHGAP11A and ARHGAP11B in invasive ductal carcinoma and assesses them as potential breast cancer biomarkers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were ARHGAP11A and ARHGAP11B expression levels measured?",{"text":118,"@type":114},"Expression levels were analyzed using data from TCGA and by qPCR in 51 IDC tumor samples compared with matched normal tissues.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationship was observed between methylation and gene overexpression?",{"text":122,"@type":114},"Promoter methylation of ARHGAP11A and ARHGAP11B showed a negative correlation with their overexpression.",{"name":124,"@type":111,"acceptedAnswer":125},"How do the genes relate to clinical features such as breastfeeding and tumor subtype?",{"text":126,"@type":114},"ARHGAP11A expression was lower in women who were breastfeeding and showed overexpression in cases with regular menstrual cycles and early menarche; ARHGAP11B was higher in HER2-positive tumors compared with HER2-positive and ER-positive categories described in the text.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},383116,1790363010,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Hindawi  \nBioMed Research International  \nVolume 2023, Article ID 8236853, 17 pages [https://doi.org/10.1155/2023/8236853](https://doi.org/10.1155/2023/8236853)  \nResearch Article  \nProtooncogenic Role ofARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers  \nY. Naeimzadeh , 1 S. Ilbeigi ,2 H. Dastsooz ,3,4,5 M. Rafiee Monjezi ,6 Y. Mansoori ,7 and S. M. B. Tabei 8  \n1School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran  \n2 Walther-Straub Institute, Ludwig-Maximilians-Universität München, Munich, Germany  \n3Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy  \n4Candiolo, C/o IRCCS, IIGM-Italian Institute for Genomic Medicine, Turin, Italy  \n5Candiolo Cancer (IT), FPO-IRCCS, Candiolo Cancer Institute, Turin, Italy  \n6Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany  \n7Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran  \n8Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran  \nCorrespondence should be addressed to S. M. B. Tabei; [tabeismb@sums.ac.ir](tabeismb@sums.ac.ir)  \nReceived 12 April 2023; Revised 22 June 2023; Accepted 31 October 2023; Published 23 November 2023  \nAcademic Editor: Yuan Li  \nCopyright © 2023 Y. Naeimzadeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nInvasive duct carcinoma (IDC) is one of the most common types of breast cancer (BC) in women worldwide, with a high risk of malignancy, metastasis, recurrence, and death. So far, molecular patterns among IDC cases have not been fully defined. However, extensive evidence has shown that dysregulated Rho family small GTPases (Rho GTPases) including Rho GTPase activating proteins (RhoGAPs) have important roles in the invasive features of IDCs. In the current study, we analyzed the expression levels of two RhoGAP genes, ARHGAP11A and ARHGAP11B, in The Cancer Genome Atlas (TCGA) breast cancer (BRCA) and also our 51 IDC tumors compared to their matched normal tissues using quantitative polymerase chain reaction (qPCR) . Our TCGA data analysis revealed higher expression of ARHGAP11A and ARHGAP11B in various cancers comprising BCs. Also, we found correlations between these genes and other genes in TCGA-BRCA. Moreover, our methylation analysis showed that their promotor methylation had a negative correlation with their overexpression. QPCR revealed their significant upregulation in our tumor samples. Furthermore, we found that the expression level of ARHGAP11A was considerably lower in women who were breastfeeding. Moreover, it had overexpression in cases who had regular menstrual cycles and early age (younger than 14) at menarche. However, ARHGAP11B had a higher expression in HER2-positive tumors versus HER2-positive and ER-positive tumors. Our study found possible protooncogenic roles for these genes and their involvement in IDCpathogenesis and malignancy. Therefore, they can be considered novel prognostic and diagnostic biomarkers for IDC.  \n1. Introduction  \nBreast cancer (BC) is one of the most common cancer-related deaths among women worldwide [1–4], with approximately 2.3 million new cancer cases and 685,000 deaths reported in 2020 [5]. Generally, the etiology of BC is multifactorial, involving genetic, lifestyle, and environmental factors as well as  \nreproductive behaviors. Several epidemiological studies have shown reproductive factors such as regular menstrual cycles, no history of breastfeeding, early age at menarche, contraceptive use, nulliparity, and first full-term gestation can increase the risk of BCs [5–9]. Based on the expression level of hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2 or ErbB2) g","cbCairm7LMJ6ERi6","https://ap.wps.com/l/cbCairm7LMJ6ERi6","pdf",2950860,17,"English","# Introduction\n## Breast cancer epidemiology and risk factors\n## Molecular subtypes and receptor-based classification\n## Histological classifications and IDC characteristics\n## Rho family GTPases and RhoGAP relevance in invasion","[{\"question\":\"What is the main focus of the study?\",\"answer\":\"The study investigates the protooncogenic role of ARHGAP11A and ARHGAP11B in invasive ductal carcinoma and assesses them as potential breast cancer biomarkers.\"},{\"question\":\"How were ARHGAP11A and ARHGAP11B expression levels measured?\",\"answer\":\"Expression levels were analyzed using data from TCGA and by qPCR in 51 IDC tumor samples compared with matched normal tissues.\"},{\"question\":\"What relationship was observed between methylation and gene overexpression?\",\"answer\":\"Promoter methylation of ARHGAP11A and ARHGAP11B showed a negative correlation with their overexpression.\"},{\"question\":\"How do the genes relate to clinical features such as breastfeeding and tumor subtype?\",\"answer\":\"ARHGAP11A expression was lower in women who were breastfeeding and showed overexpression in cases with regular menstrual cycles and early menarche; ARHGAP11B was higher in HER2-positive tumors compared with HER2-positive and ER-positive categories described in the text.\"}]","Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma - Two Promising Breast Cancer Biomarkers | PDF",1790254336,43]